-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

613. Acute Myeloid Leukemias: Clinical and Epidemiological: Poster III

Symposia: Acute Myeloid Leukemias: Clinical and Epidemiological Program: Oral and Poster Abstracts
Type: Poster
Monday, December 12, 2022: 6:00 PM-8:00 PM
Hall D (Ernest N. Morial Convention Center)

Wolfgang Kern, MD1, Prashant R. Tembhare, MD2, Reza Nejati, MD3*, Fatima Zahra Jelloul, MD4*, Wencke Walter, PhD1*, Joseph D. Khoury, MD, FCAP5,6 and Torsten Haferlach, MD1

1MLL Munich Leukemia Laboratory, Munich, Germany
2Hematopathology Lab, Tata Memorial Centre, Affiliated to Homi Bhabha National Institute, Mumbai, India
3Department of Pathology, Fox Chase Cancer Center, Philadelphia, PA
4Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
5University of Nebraska Medical Center, Omaha, NE
6The University of Texas MD Anderson Cancer Center, Houston

Jan Philipp Bewersdorf, MD1,2, Vanessa Hasle3*, Rory M. Shallis, MD4, Ethan G. Thompson, PhD3*, Daniel Lopes de Menezes, PhD3*, Shelonitda Rose5, Isaac W. Boss, PhD6*, Stephanie Halene, MD7, Torsten Haferlach, MD8, Brian Fox9* and Amer M. Zeidan, MD10

1Department of Medicine; Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY
2Department of Internal Medicine, YALE UNIVERSITY SCHOOL OF MEDICINE, New Haven, CT
3Bristol Myers Squibb, Princeton, NJ
4Department of Internal Medicine, School of Medicine and Yale Cancer Center, Yale University, New Haven, CT
5Bristol Myers Squibb, Summit, NJ
6Translational Research, Bristol Myers Squibb, Seattle, WA
7Section of Hematology, Department of Internal Medicine, Yale University School of Medicine and Yale Cancer Center, New Haven, CT
8MLL Munich Leukemia Laboratory, Munich, Germany
9Bristol-Myers Squibb Company, Princeton, NJ
10Yale University and Yale Cancer Center, New Haven, CT

Sayantanee Dutta, PhD1*, Paul Kerbs, Dr.2,3,4,5*, Maja Rothenberg-Thurley, PhD6*, Bianka Ksienzyk7,8*, Stefan Krebs, PhD9,10*, Helmut Blum9*, Karsten Spiekermann2,3,11,12,13, Klaus H Metzeler, MD14, Tobias Herold, MD15, Sebastian Vosberg, PhD16* and Philipp A. Greif3,5,17

1Hematology, Medical University Graz, Graz, Austria
2German Cancer Research Center (DKFZ), Heidelberg, Germany
3German Consortium for Translational Cancer Research (DKTK), Partner Site Munich, Munich, Germany
4Ludwig Maximilian University of Munich, Munich, Germany
5German Cancer Consortium (DKTK), Munich, Germany
6Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany
7Experimental Leukemia and Lymphoma Research, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany
8Department of Medicine III, University Hospital, LMU Munich, Munich, Germany
9Laboratory for Functional Genome Analysis (LAFUGA), Gene Center, LMU Munich, Munich, Germany
10Laboratory for Functional Genome Analysis, Gene-Center, Ludwig-Maximilians-University, Munich, Germany
11Experimental Leukemia and Lymphoma Research (ELLF), Department of Internal Medicine III, University Hospital, LMU Munich, Munich, Germany
12Department of Medicine III, Laboratory for Leukemia Diagnostics (LfL), University Hospital, LMU Munich, Munich, Germany
13German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany
14Department of Hematology, Cell Therapy and Hemostaseology, University Hospital Leipzig, Leipzig, Germany
15Laboratory for Leukemia Diagnostics, Department of Medicine III, Ludwig-maximilians-Universitaet (LMU), Munich, Bavaria, Germany
16Division of Oncology, Medical University of Graz, Graz, Austria
17Department of Medicine III, University Hospital Grosshadern, Ludwig-Maximilians University, Munich, Germany

Atsushi Marumo, MD1*, Satoshi Wakita, MD, PhD1*, Kaoru Morita, MD, PhD2*, Shinichi Kako3, Takashi Toya4, Yuho Najima5, Noriko Doki6*, Junya Kanda, MD, PhD7, Junya Kuroda, MD, PhD8, Shin-Ichiro Mori, MD9*, Atsushi Satake, MD, PhD10, Kensuke Usuki, MD, PhD11, Toshimitsu Ueki, MD12*, Nobuhiko Uoshima, MD, PhD13*, Yutaka Kobayashi, MD, PhD14*, Eri Kawata, MD, PhD15, Kazutaka Nakayama16*, Yuhei Nagao17*, Katsuhiro Shono, MD, PhD17*, Motoharu Shibusawa18*, Jiro Tadokoro19*, Masao Hagihara, MD20*, Hitoji Uchiyama, MD, PhD21*, Naoyuki Uchida, MD, PhD22, Yasushi Kubota, MD, PhD23*, Shinya Kimura, MD, PhD24*, Hisao Nagoshi25*, Tatsuo Ichinohe26, Saiko Kurosawa27*, Sayuri Motomura, MD, PhD28, Hashimoto Akiko, MD29*, Hideharu Muto, MD, PhD30*, Eriko Sato, MD, PhD31*, Masao Ogata, MD, PhD32*, Kenjiro Mitsuhashi33*, Jun Ando, MD, PhD34*, Haruko Tashiro, M.D., Ph.D.35*, Masahiro Sakaguchi1*, Shunsuke Yui1*, Kunihito Arai1*, Tomoaki Kitano1*, Miho Miyata36*, Takahiro Fukuda37*, Yoshinobu Kanda, MD, PhD38 and Hiroki Yamaguchi, MD, PhD1

1Department of Hematology, Nippon Medical School, Tokyo, Japan
2Division of Hematology, Jichi Medical University, Tochigi, Japan
3Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan
4Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan
5Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Tokyo, TKY, Japan
6Division of Hematology, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan
7Department of Hematology and Oncology, Kyoto University, Kyoto, Japan
8Division of Hematology and Oncology, Deparment of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan
9St. Luke's International Hospital, Chuo-Ku, TKY, JPN
10Kansai Medical University, Osaka, Japan
11Department of Hematology, NTT Medical Center Tokyo, Tokyo, Japan
12Nagano Redcross Hospital, Nagano, JPN
13Department of Hematology, Japanese Red Cross Kyoto Daini Hospital, Kyoto, Japan
14Department of Hematology, Japan Red Cross Kyoto Daini Hospital, Kyoto, Japan
15Department of Hematology, Panasonic Health Insurance Organization, Matsushita Memorial Hospital, Osaka, KYO, Japan
16Yokohama Minami Kyousai Hospital, Kanagawa, Japan
17Department of Hematology, Chiba Aoba Municipal Hospital, Chiba, Japan
18Department of Hematology, IMS group Shinmatsudo Central General Hospital, Chiba, Japan
19Shinmatsudo Central General Hospital, Matsudo-Shi, Chiba-Ken, JPN
20Department of Hematology, EIJU GENERAL HOSPITAL, Taito-Ku, Japan
21Department of Hematology, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan
22Department of Hematology, Federation of National Public Service Personnel Mutual Aid Associations, Toranomon Hospital, Tokyo, Japan
23Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga, Japan
24Saga University, Saga, Japan
25Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan
26Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan
27Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan
28Tokyo Metropoloitan Tama-Hokubu Medical Center, Higashimurayama-shi, JPN
29Kobe City Nishi-Kobe Medical Center,, Hyogo, Japan
30Division of hematology, Tokyo Metropolitan Otsuka Hospital, Tokyo, Japan
31Department of Hematology, Juntendo University Nerima Hospital, Tokyo, Japan
32Department of Hematology, Oita University, Yufu, Japan
33Saitama Red Cross Hospital, Saitama, Japan
34Department of Hematology, Juntendo University of Medicine, Tokyo, Japan
35Department of Hematology/Oncology, Teikyo University School of Medicine, Itabashi-ku, Japan
36Department of Hematology, Nippon Medical School, Tokyo, JPN
37Hematopoietic Stem Cell Transplantation Division, National Cancer Center Hospital, Tokyo, Japan
38Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama City, Japan

Uday Prakash Kulkarni, MD1*, Sushil Selvarajan, MD, DM1*, Fouzia NA, DNB, DM1*, Sharon Lionel, MBBS, MD, DM1*, Sukesh C Nair, DCP DNB MD FRCPA2*, Poonkuzhali Balasubramanian, MSc, PhD1, Thenmozhi Mani, PhD3*, Aby Abraham, MD, DM1*, Biju George, MD, DM1 and Vikram Mathews, MD, DM1

1Department of Haematology, Christian Medical College, Vellore, India
2Department of Transfusion Medicine and Immunohaematology, Christian Medical College, Vellore, India
3Department of Biostatistics, Christian Medical College, Vellore, India

Jorge Labrador1,2*, Josefina Serrano3*, Laura Torres4*, Evelyn Acuña-Cruz, MD5*, Jose A. Perez-Simon, MD, PhD6, Maria Lopez-Pavia7*, Gabriela Rodriguez Macias, MD8*, Carmen Botella9*, Carlos Rodriguez10*, Pilar Martinez Sanchez, MD11*, Maria Luz Amigo, MD12*, Maria Victoria Cuevas13*, Teresa Bernal del Castillo, MD14*, María Carmen Montes15*, Celina Benavente16*, Juan Ignacio Rodriguez-Gutierrez17*, Mar Tormo18, Raimundo García-Boyero19*, Aurelio Lopez Martínez, MD20*, Rafael Lluch Garcia, MD21*, Jesús Lorenzo Algarra, MD22*, Esperanza Lavilla23*, David Martinez-Cuadron24*, Miguel A. Sanz, MD25,26 and Pau Montesinos, MD, PhD27*

1Facultad de Ciencias de la Salud, Universidad Isabel I, Burgos, Spain
2Hematology Department, Research Unit, Hospital Universitario de Burgos, Burgos, Spain
3Hospital Universitario Reina Sofía, Córdoba, Spain
4Hospital Universitari I Politécnic La Fe, Valencia, Spain
5Hospital Universitario y Politécnico La Fe, Valencia, Spain
6Instituto de Biomedicina de Sevilla (IBiS), UGC-Hematología, Hospital Universitario Virgen del Rocío/ CSIC/ CIBERONC, Universidad de Sevilla, Sevilla, Spain
7Hospital General de Valencia, Valencia, Spain
8Hematology and hemotherapy department, Hospital General Universitario Gregorio Marañón, Madrid, Spain
9Hospital General Universitario de Alicante, Alicante, Spain
10Hospital Universitario de Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria, Spain
11Clinical Hematology, Hospital Universitario 12 de Octubre, Madrid, Spain
12Hospital Universitario Morales Messeguer, Murcia, Spain
13Hospital Universitario de Burgos, Burgos, Spain
14Hospital Universitario Central de Asturias, Instituto Universitario (IUOPA), Instituto de investigación del Principado de Asturias (ISPA),, Oviedo, ESP
15Complejo Asistencial de Zamora, Zamora, Spain
16Hospital Clinico San Carlos. Madrid, Madrid, Spain
17Hospital Universitario Basurto, Bilbao, Spain
18Hospital Clinico Universitario Valencia, Valencia, Spain
19Hospital General Universitario de Castellón, Castellón de la Plana, Spain
20Hospital Arnau de Vilanova, Lleida, Spain
21Hospital de La Ribera, Alzira, Spain
22Hematology department, Complejo Hospitalario Universitario de Albacete, Albacete, Spain
23Hospital Universitario Lucus Augusti, Lugo, Spain
24Instituto de Investigación Sanitaria La Fe (IISLAFE), Hematology Department, Hospital Universitari i Politécnic-IIS La Fe, Valencia, Spain
25Programa Español de Tratamientos en Hematologia, PETHEMA, Valencia, Spain
26Hematology Department, Hospital Universitari i Politècnic La Fe, Valencia, Spain
27Hospital Universitari i Politècnic La Fe, Instituto de Investigación Sanitaria La Fe (IISLAFE), Valencia, Spain

Rory M. Shallis, MD1, Julian Weiss1*, Eric S. Winer, MD2, Talha Badar, MD3, Alok Swaroop4*, Peter Doukas4*, Emily Geramita, MD, PhD5, Henry Le6*, Sonal Agarwal, PharmD6*, Man Yee Merl6*, Annie Im, MD7, Yasmin Abaza, MD8, Mark R. Litzow, MD9 and Nikolai A. Podoltsev, MD, PhD1

1Yale University School of Medicine, New Haven, CT
2Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
3Division of Hematology and Oncology, Mayo Clinic Florida, Jacksonville, FL
4Northwestern University, Chicago
5Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA
6Department of Pharmacy Services, Smilow Cancer Hospital at Yale New Haven Health, New Haven
7Univ. of Pittsburgh Cancer Institute, Pittsburgh, PA
8Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL
9Division of Hematology, Mayo Clinic, Rochester, MN

Bart L. Scott, MD1, Michael R. Savona, MD2, Gail J. Roboz, MD3, Karen Seiter4, Daniel A. Pollyea, MD5, Irene S. DeGutis6*, Pavel Kiselev6*, Edward Yu, ScD6*, Ali McBride6, Willem Heydendael, PhD6* and Harry P. Erba, MD, PhD7

1Fred Hutchinson Cancer Research Center, Seattle, WA
2Vanderbilt-Ingram Cancer Center, Nashville, TN
3Weill Cornell Medicine and New York-Presbyterian Hospital, New York, NY
4New York Medical College, Valhalla, NY
5University of Colorado, Aurora, CO
6Bristol Myers Squibb, Princeton, NJ
7Duke University, Durham, NC

Margaret Li Krackeler, MD1, Benjamin Moskoff, PharmD2*, Tamer Othman, MD3*, Tali Azenkot, MD1*, Ryan J. Beechinor, PharmD2*, Aaron S Rosenberg, MD4, Naseem S Esteghamat, MD4, Rasmus T Hoeg, MD4*, Joseph M Tuscano, MD4 and Brian A. Jonas, MD, PhD5

1Department of Internal Medicine, University of California Davis School of Medicine, Sacramento, CA
2Pharmacy Department, University of California Davis School of Medicine, Sacramento, CA
3University of California Davis Comprehensive Cancer Center, Sacramento, CA
4Department of Internal Medicine, Division of Cellular Therapy, Bone Marrow Transplantation and Malignant Hematology, University of California Davis School of Medicine, Sacramento, CA
5Department of Internal Medicine, Division of Malignant Hematology, Transplantation and Cellular Therapy, University of California Davis School of Medicine, Sacramento, CA

Zachery Clint Branham, DO1*, Chijioke Okereke, MD2*, Mahran Shoukier, MD3*, Danielle Bradshaw, MD4*, Ravindra Kolhe, MD, PhD5*, Anand P. Jillella, MD4 and Vamsi K. Kota, MD4

1Augusta University, Augusta, GA
2Department of Internal Medicine, Medical College of Georgia at Augusta University, Augusta, GA
3Georgia Cancer Center, Augusta University, Augusta, GA
4Division of Hematology/Oncology, Georgia Cancer Center at Augusta University, Augusta, GA
5Department of Pathology, Augusta University, Augusta, GA

Fabio Guolo, MD1,2*, Paola Minetto, MD, PhD1, Carola Riva, MD1*, Chiara Vernarecci, MD1*, Monica Passannante, MD1*, Francesca Parodi3*, Michela Frello, MD1*, Elena Maio3*, Beatrice Ferro3*, Maria Chies3*, Maurizio Miglino, MD, PhD4*, Elisabetta Tedone5*, Nicoletta Colombo, PhD5*, Enrico Carminati1*, Clara Nurra1*, Francesco Puglisi3*, Antonia Cagnetta, MD1*, Michele Cea1* and Roberto Massimo Lemoli, MD1,6

1Clinic of Hematology, Department of Internal Medicine (DiMI), IRCCS Ospedale Policlinico San Martino, Genova, Italy
2Clinic of Hematology, Department of Internal Medicine (DiMI), Policlinico San Martino, IRCCS per l’Oncologia, University of Genoa, Genoa, Italy
3University of Genoa, Genoa, Italy
4IRCCS San Martino Hospital, Genoa, Italy
5Clinical Flow Cytometry Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy
6Clinic of Hematology, Department of Internal Medicine (DiMI),IRCCS per l’Oncologia, University of Genoa, Genoa, Italy

Anna Moseley1*, Boris Freidlin, PHD2*, Rory M. Shallis, MD3, Amer M. Zeidan, MD4, David A. Sallman, MD5, Richard F. Little, MD, MPH6, Harry P. Erba, MD, PhD7, Michael L. Leblanc, PhD8* and Megan Othus, PhD9

1SWOG Statistical Center, Fred Hutchinson Cancer Center, Seattle, WA
2Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD
3Yale University School of Medicine, New Haven, CT
4Department of Internal Medicine, Yale School of Medicine and Yale Cancer Center, New Haven, CT
5Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
6National Cancer Institute, Washington, DC
7Leukemia Program, Duke University Medical Center, Durham, NC
8SWOG Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, WA
9Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA

Brandon J Kale, MD1*, Grace Hwang, PharmD2*, Purnima Sravanti Teegavarapu, MD3,4,5, Martha P. Mims, MD, PhD3,4,5 and Gustavo Rivero, MD3,4,5

1Department of Medicine, Baylor College of Medicine, Houston, TX
2Department of Pharmacy, Baylor St.Luke's Medical Center, Houston, TX
3Department of Hematology/Oncology, Baylor St Luke's Medical Center, Houston, TX
4Department of Medicine, Hematology/Oncology, Baylor College of Medicine, Houston, TX
5Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine, Houston, TX

Cristobal Augusto Frutos Ortiz, MD1*, Lidiane Andino2*, Alfredo Reinaldo Quiroz, MD1*, Dietger Niederwieser, MD3, Maria Elvira Enciso, MD4*, Aline Nicole Paats, MD4* and Victor Salinas5*

1Department of Hematology, Instituto de Prevision Social, Asuncion, Paraguay
2Hematology Service, Hospital Central del Instituto de Previsión Social, Asuncion, Paraguay
3University of Leipzig, Leipzig, Germany
4Instituto de Prevision Social, Asuncion, Paraguay
5Sociedad Paraguaya de Hematología y Hemoterapia, Asuncion, Paraguay

Shai Shimony, MD1,2*, Geoffrey G Fell3*, Evan C. Chen, MD2, Harrison Tsai4*, Martha Wadleigh, MD2, Eric S. Winer, MD2, Jacqueline S. Garcia, MD2, Marlise R. Luskin, MD2, Maximilian F. Stahl, MD2, Donna S. Neuberg, ScD3, Daniel J DeAngelo, MD, PhD5, R. Coleman Lindsley6 and Richard M. Stone, MD5

1Rabin Medical Center and Faculty of Medicine, Tel Aviv University, Petah Tikva, ISR
2Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
3Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
4Department of Pathology Boston Children’s Hospital, Boston, MA
5Center for Leukemia, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
6Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA

Clement Dove Okello, MD1*, Soheil Meshinchi, M.D., Ph.D.2, Katherine Tarlock, MD3, Edus H. Warren, MD, PhD4,5,6, Andrea M. H. Towlerton7*, Henry Ddungu1, Yusuf Mulumba1*, Fadhil Geriga, MBChB1*, Jackson Orem, MBChB, MMed, PhD1 and Joyce K. Balagadde1*

1Uganda Cancer Institute, Kampala, Uganda
2Fred Hutchinson Cancer Center, Seattle, WA
3Department of Pediatrics, University of Washington, Seattle, WA
4Division of Hematology and Medical Oncology, University of Washington, Seattle, WA
5Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
6Seattle Cancer Care Alliance, Seattle, WA
7Fred Hutchinson Cancer Research Center, Seattle, WA

Khaldun Obeidat1*, Ekrem Turk, MD1*, Vaishali Deenadayalan, MD1, Rafaella Litvin, MD1*, Maryam Zia1,2 and Shelby D. Rifkin, MD1

1John H Stroger Jr Hospital of Cook County, Chicago, IL
2Division of Hematology/Oncology, University of Illinois College of Medicine At Chicago, Chicago, IL

Robert Zeiser, MD1,2, Christoph Schmid, MD3*, Gheath Alatrash, PhD, DO4,5, Ron Ram, MD6*, Yuan Wu7*, Hans-Jochen Jochen Weber, PhD8*, Stephanie Grzesiak9*, Lamis K. Eldjerou, MD10 and Charles Craddock11

1University Medical Center Freiburg, Freiburg, Germany
2Department of Medicine I, Faculty of Medicine, Medical Center, University of Freiburg, Freiburg, Germany
3Department of Hematology and Oncology / Stem Cell Transplantation, Augsburg University Hospital and Medical Faculty, Augsburg, Germany
4Department of Hematopoietic Biology & Malignancy, The University of Texas MD Anderson Cancer Center, Pearland, TX
5Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
6BMT Unit, Tel Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
7Oncology Analytics, Novartis Pharmaceuticals, Basel, Switzerland
8Novartis Pharma AG, Basel, Switzerland
9Novartis Pharmaceuticals, Basel, Switzerland
10Novartis Pharmaceuticals Corporation, East Hanover, NJ
11Department of Haematology, University Hospital Birmingham NHS Trust, Queen Elizabeth Medical Centre, Birmingham, ENG, United Kingdom

Volkan Karakuş, Assoc. Prof1*, Omur Gokmen Sevindik, Prof2, Aylin Karatas3*, Emel Merve Yenihayat, M.D4*, Merve Gokcen Polat, M.D4*, Serhat Çelik, M.D5*, Ibrahim Ethem Pinar, M.D6*, Ali Dogan, M.D7*, Idris İnce, M.D8*, Umit Yavuz Malkan9*, Utku Iltar, M.D10*, Demircan Özdalcı Ozdalcı11*, Özgür Mehtap, MD12*, Ramazan Erdem, M.D13*, Murat Kacmaz, M.D14*, Fatma Aykas, M.D15*, Berna Ozturk, M.D16*, Burak Deveci, MD17*, Aydan Akdeniz, M.D18*, Hale Bulbul, M.D19*, Sureyya Yigit Kaya, MD20*, Ferda Can, M.D21*, Zeynep Guven, MD22*, Ceyda Aslan, M.D23*, Muzaffer Keklik, MD24*, Fahir Ozkalemkas, MD25*, Hakan Goker, MD, PROF26* and İnci Alacacıoğlu, M.D.27*

1Department of Hematology, Antalya Research and Training Hospital, Antalya, Turkey
2Department of Hematology, Medipol University International School of Medicine, Istanbul, Turkey
3Dokuz Eylul University, Faculty of Medicine, Izmir, TUR
4Kocaeli University Hospital, Kocaeli, Turkey
5Erciyes University, Faculty of Medicine, Hematology Department, Kayseri, Turkey
6Bursa Uludag University Hospital, Bursa, Turkey
7Van Yüzüncü Yıl University Hospital, van, Turkey
8Gaziantep Dr. Ersin Arslan Training and Research Hospital, Gaziantep, Turkey
9Hacettepe University Hospitals, Ankara, Turkey
10Akdeniz University Health Practice and Research Hospital, Antalya, Turkey
11Suleyman Demirel University Research and Application Hospital, Isparta, Turkey
12Department of Hematology, Kocaeli University, Kocaeli, Turkey
13Ministry of Health Antalya Provincial Health Directorate Antalya Training and Research Hospital, Antalya, Turkey
14Hatay Mustafa Kemal University, Hatay, Turkey
15Republic of Turkey Ministry of Health Antalya Provincial Health Directorate Antalya Training and Research Hospital, Antalya, Turkey
16Diskapi Yildirim Beyazit Training and Research Hospital, Ankara, Turkey
17Medstar Hospital, Antalya, Turkey
18Mersin University, Mersin, Turkey
19HEALTH SCIENCES UNIVERSITY İZMİR TEPECİK EDUCATION AND RESEARCH HOSPITAL, Izmır, Turkey
20Manisa Cıty Hospital, Manisa, Turkey
21Ankara City Hospital, Ankara, Turkey
22Nigde Training and Research Hospital, Nigde, Turkey
23Kocaeli Derince Training and Research Hospital, Kocaeli, Turkey
24Erciyes University, Kayseri, TUR
25Hematology, Uludag University Faculty of Medicine, Bursa, Turkey
26Department of Internal Medicine, Division of Hematology, Hacettepe University, Ankara, AE, Turkey
27Department of Internal Medicine, Division of Hematology, Dokuz Eylül University School of Medicine, İzmir, Turkey

Michal Jakub Kubiak, MD1, Anand P. Jillella, MD2, Danielle Bradshaw, MD2*, Natasha M. Savage, MD3, Ravindra Kolhe, MD, PhD4*, Locke J. Bryan, MD2 and Vamsi K. Kota, MD2

1Augusta University, Augusta, GA
2Division of Hematology/Oncology, Georgia Cancer Center at Augusta University, Augusta, GA
3Department of Pathology, Augusta University Medical Center, Augusta, GA
4Department of Pathology, Augusta University, Augusta, GA

Naoki Miyashita, M.D.1*, Masahiro Onozawa, M.D., Ph.D.1, Shota Yoshida, MD1*, Hiroyuki Kimura, M.D.1*, Shogo Takahashi, M.D.1*, Shota Yokoyama1*, Toshihiro Matsukawa, M.D., Ph.D.1*, Shinsuke Hirabayashi, M.D, Ph.D.2*, Shinichi Fujisawa3*, Akio Mori, MD, PhD4, Shuichi Ota, M.D., Ph.D.5, Yasutaka Kakinoki, M.D., Ph.D.6*, Yutaka Tsutsumi, M.D., Ph.D.7*, Satoshi Yamamoto, M.D., Ph.D.8*, Takuto Miyagishima, M.D., Ph.D.9*, Takahiro Nagashima, M.D., Ph.D.10*, Makoto Ibata, M.D., Ph.D.11*, Hajime Kobayashi, M.D, Ph.D.12*, Yoshihito Haseyama, M.D, Ph.D.13*, Katsuya Fujimoto, M.D, Ph.D.14*, Toshimichi Ishihara, M.D., Ph.D.15*, Hajime Sakai, M.D, Ph.D.16, Takeshi Kondo4 and Takanori Teshima, M.D., Ph.D.1,3

1Department of Hematology, Hokkaido University Faculty of Medicine, Sapporo, Japan
2Department of Pediatrics, Hokkaido University, Graduate school of Medicine, Sapporo, Japan
3Division of Laboratory and Transfusion Medicine, Hokkaido University Hospital, Sapporo, Japan
4Blood Disorders Center, Aiiku Hospital, Sapporo, Japan
5Department of Hematology, Sapporo Hokuyu Hospital, Sapporo, Japan
6Department of Hematology, Asahikawa City Hospital, Asahikawa, Japan
7Department of Hematology, Hakodate Municipal Hospital, Hakodate, Japan
8Department of Hematology, Sapporo City General Hospital, Sapporo, Japan
9Department of Hematology, Kushiro Rosai Hospital, Kushiro, Japan
10Department of Internal Medicine, Kitami Red Cross Hospital, Kitami, Japan
11Department of Hematology, Sapporo-Kosei General Hospital, Sapporo, Japan
12Department of Hematology, Obihiro Kosei Hospital, Obhiro, Japan
13Department of Hematology, Tonan Hospital, Sapporo, Japan
14Department of Hematology, National Hospital Organization Hokkaido Cancer Center, Sapporo, Japan
15Department of Hematology, Kin-ikyo Chuo Hospital, Sapporo, Japan
16Department of Hematology, Teine Keijinkai Hospital, Sapporo, Japan

Elliot C. Smith, MD1,2*, Eshetu G. Atenafu, M.Sc., P.Stat3*, Aniket Bankar, MBBS, MD, DM1, Steven M. Chan, MD, PhD1, Marta B. Davidson, MD, PhD1, Vikas Gupta, MD, FRCP, FRCPath1,2, Mark D. Minden, MD, PhD1,2, Guillaume Richard-Carpentier, MD, FRCPC1, Aaron D. Schimmer, MD, PhD2,4, Andre C. Schuh, MD2,4, Hassan Sibai, MBBS, MD2,5*, Karen Yee, MD2,5 and Dawn Maze, MD, FRCPC, MSc1,2

1Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
2Department of Medicine, University of Toronto, Toronto, ON, Canada
3Department of Biostatistics, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
4Division of Medical Oncology and Hematology, University Health Network, Toronto, ON, Canada
5Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada

Tareq Abuasab, MD1, Srdan Verstovsek, MD, PhD1, Gautam Borthakur, MD1, Rashmi Kanagal-Shamanna, MD2, Keyur Patel, MD, PhD2*, Koichi Takahashi, MD, PhD3, Lucia Masarova, MD1, Prithviraj Bose, MD4, John Villarreal1*, Sherry A. Pierce, BSN, BA1*, Guillermo Montalban-Bravo, MD1, Guillermo Garcia-Manero, MD5, Nicholas Short, MD1, Courtney D. DiNardo, MD, MSCE1, Naval Daver, MD1, Farhad Ravandi, MD1, Hagop Kantarjian, MD1 and Musa Yilmaz, MD1

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX
4The University of Texas MD Anderson Cancer Center, Houston, TX
5Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX

Jiale Ma1,2*, Chunhua Song, MD,PhD3,4 and Zheng Ge, MD, PhD1

1Department of Hematology, Zhongda Hospital, School of Medicine, Institute of Hematology, Southeast University, Nanjing, China
2Department of Hematology,Xuzhou Central Hospital, Xuzhou, China
3Hershey Medical Center, Pennsylvania State University Medical College, Hershey
4Division of Hematology, The Ohio State University Wexner Medical Center, the James Cancer Hospital, Columbus

Omer H Jamy, MD1, Kendall Diebold, CRNP2*, Kimo Bachiashvili, MD3, Sravanti Rangaraju, MBBS4, Pankit Vachhani, MD5*, Kelly N. Godby, MD6*, Donna Salzman, MD7 and Ravi Bhatia, MD1

1Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL
2University of Alabama at Birmingham, Birmingham
3O’ Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL
4University of Alabama at Birmingham, Birmingham, AL
5O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL
6Department of Medicine, Division of Hematology/Oncology, University of Alabama at Birmingham Hospital, Birmingham, AL
7Divison of Hematology/Oncology, University of Alabama at Birmingham, Birmingham, AL

Raffaele Palmieri, raffaele.f.palmieri@gmail.com1*, Simona Iacobelli2*, Giovangiacinto Paterno, MD3*, Moretti Federico4*, Elisa Buzzatti, MD4*, Meddi Elisa5*, Savi Arianna4*, Gentiana Trotta4*, Flavia Mallegni4*, Maria Ilaria Del Principe, MD6*, Luca Maurillo, MD7*, Maria Teresa Voso, MD8, Adriano Venditti, MD9 and Francesco Buccisano, MD10

1Università Tor Vergata - Fondazione Policlinico Tor Vergata, Roma, ITA
2Department of Biology, Centro Di Biostatistica E Bioinformatica Università Tor Vergata, Rome, Italy
3Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy
4Ematologia Dipartimento di Biomedicina e Prevenzione, Università di Roma “Tor Vergata”, Rome, Italy
5Ematologia Dipartimento di Biomedicina e Prevenzione, Università di Roma “Tor Vergata, Rome, Italy
6Ematologia, Dipartimento di Biomedicina e Prevenzione, Università degli studi di Roma Tor Vergata, Roma, Italy
7Department of Onco-Hematology, Policlinico Tor Vergata, Rome, Rome, Italy
8Department of Biomedicine and Prevention, University of Rome “Tor Vergata”, Rome, Italy
9Hematology, Department of Biomedicine and Prevention, University Tor Vergata, Rome, Italy
10Hematology, Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy

Alejandra Romero, MD1*, Francisca Bass, MD2*, Veronica Lizama, MD3*, Christine Rojas4*, Javier Diaz, MD5*, Marisa Capurro, MD6*, Yaima Gutierrez, MD6*, Matias Sanchez, MD7, Natalia Aránguiz, MD8*, Marcela Espinoza, MD9*, Maria Carolina Guerra, MD10*, Sebastian Hidalgo, MD11*, Joaquín Jerez, MD12*, Pilar León, MD13*, Bernardita Rojas, MD14*, Ernesto Castaño, MD15*, Denis Suarez Munoz, MD16*, Vivianne Torres, MD17*, Monica Paulina Fuentes, MD17*, Miguel Lopez, MD18*, Rocío Osorio, MD19*, Belkys Mercedes Linares, MD20*, Robert Holloway Melo, MD21*, Paola Aravena, MD22*, Patricia Fardella, MD23*, Felipe Ramirez, MD24*, Constanza Flores, MD24*, Maria Soledad Urquieta, MD25*, David Martinez-Cuadron26* and Pau Montesinos, PhD, MD27,28*

1Hospital Guillermo Grant Benavente, Concepción, Chile
2Hospital del Salvador, Santiago, Chile
3Hospital del Salvador, Santiago, Región Metropolitana, CHL
4Hospital Gustavo Fricke, Viña del Mar, Valparaíso, Chile
5Hospital Gustavo Fricke, Viña del Mar, CHL
6Hospital de Temuco, Temuco, Chile
7Clinica Alemana de Santiago, New York, NY
8Clinica Alemana, Santiago, Chile
9Clinica Dávila, Santiago, Chile
10Fundación Arturo López Pérez, SANTIAGO, CHL
11Fundación Arturo López Pérez, Santiago, CHL
12Fundación Arturo López Pérez, Santiago, Chile
13Hospital Van Buren, Valparaiso, Chile
14Hospital Van Buren, Viña Del Mar, CHL
15Hospital Sótero del Río, Santiago, Chile
16Hospital Sotero Del Río, Santiago, CHL
17Hospital Base de Valdivia, Valdivia, Chile
18Hospital Universidad de Chile, Santiago, Chile
19Hospital de Arica, Arica, Chile
20Hospital DIPRECA, Santiago, Metropolitana DE Santiago, CHL
21Hospital Dipreca, SANTIAGO, CHL
22Clinica Las Condes, SANTIAGO, CHL
23Clinica Las Condes, Santiago, Chile
24Hospital San Juan de Dios, La Serena, Chile
25Hospital Naval, Viña del Mar, Chile
26Hospital Universitario La Fe, Valencia, Valencia, Spain
27Hospital Politecnico Universitario La Fe, Valencia, Spain, Spain
28Hematology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain

*signifies non-member of ASH